UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000010845
Receipt number R000012698
Scientific Title Phase II trial with abraxane and trastuzumab for advanced/recurrent HER2-positive breast cancer
Date of disclosure of the study information 2013/06/15
Last modified on 2013/05/31 11:13:24

No. Disposal Last modified on Item of update
1 Insert 2013/05/31 11:13:38